140 related articles for article (PubMed ID: 8748608)
1. Basic research in substantia nigra and ventral tegmental area: clinical implications.
Stratta F; Bonci A; Calabresi P; Stefani A; Pisani A; Bernardi G; Mercuri NB
J Neural Transm Suppl; 1995; 45():47-55. PubMed ID: 8748608
[TBL] [Abstract][Full Text] [Related]
2. Insomnia following hypocretin2-saporin lesions of the substantia nigra.
Gerashchenko D; Blanco-Centurion CA; Miller JD; Shiromani PJ
Neuroscience; 2006; 137(1):29-36. PubMed ID: 16289583
[TBL] [Abstract][Full Text] [Related]
3. Subcellular distribution and plasticity of neurokinin-1 receptors in the rat substantia nigra and ventral tegmental area.
Lessard A; Pickel VM
Neuroscience; 2005; 135(4):1309-23. PubMed ID: 16165296
[TBL] [Abstract][Full Text] [Related]
4. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
Maingay M; Romero-Ramos M; Carta M; Kirik D
Neurobiol Dis; 2006 Sep; 23(3):522-32. PubMed ID: 16806952
[TBL] [Abstract][Full Text] [Related]
5. Quetiapine increases the firing rate of rat substantia nigra and ventral tegmental area dopamine neurons in vitro.
Werkman TR; Olijslagers JE; Perlstein B; Jansen AH; McCreary AC; Kruse CG; Wadman WJ
Eur J Pharmacol; 2004 Dec; 506(1):47-53. PubMed ID: 15588623
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease is a neuropsychiatric disorder.
Agid Y; Arnulf I; Bejjani P; Bloch F; Bonnet AM; Damier P; Dubois B; François C; Houeto JL; Iacono D; Karachi C; Mesnage V; Messouak O; Vidailhet M; Welter ML; Yelnik J
Adv Neurol; 2003; 91():365-70. PubMed ID: 12442695
[No Abstract] [Full Text] [Related]
7. Dopaminergic graft-induced long-term recovery of complex sensorimotor behaviors in a rat model of Parkinson's disease.
Nikkhah G; Rosenthal C; Falkenstein G; Samii M
Zentralbl Neurochir; 1998; 59(2):97-103. PubMed ID: 9674098
[TBL] [Abstract][Full Text] [Related]
8. Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons.
Keath JR; Iacoviello MP; Barrett LE; Mansvelder HD; McGehee DS
J Neurophysiol; 2007 Dec; 98(6):3388-96. PubMed ID: 17942622
[TBL] [Abstract][Full Text] [Related]
9. Midbrain muscarinic receptors modulate morphine-induced accumbal and striatal dopamine efflux in the rat.
Miller AD; Forster GL; Yeomans JS; Blaha CD
Neuroscience; 2005; 136(2):531-8. PubMed ID: 16216430
[TBL] [Abstract][Full Text] [Related]
10. Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias).
Barbeau A
Neurotoxicology; 1984; 5(1):13-35. PubMed ID: 6538948
[TBL] [Abstract][Full Text] [Related]
11. Does the cerebral cortex exacerbate dopaminergic cell death in the substantia nigra of 6OHDA-lesioned rats?
Luquin N; Mitrofanis J
Parkinsonism Relat Disord; 2008; 14(3):213-23. PubMed ID: 18029221
[TBL] [Abstract][Full Text] [Related]
12. Effects of acute and repeated administration of amisulpride, a dopamine D2/D3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons.
Di Giovanni G; Di Mascio M; Di Matteo V; Esposito E
J Pharmacol Exp Ther; 1998 Oct; 287(1):51-7. PubMed ID: 9765321
[TBL] [Abstract][Full Text] [Related]
13. [Dopaminergic conception of Parkinsonism and its treatment with L-DOPA].
Levin SL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(9):1418-26. PubMed ID: 4349303
[No Abstract] [Full Text] [Related]
14. K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons.
Liss B; Haeckel O; Wildmann J; Miki T; Seino S; Roeper J
Nat Neurosci; 2005 Dec; 8(12):1742-51. PubMed ID: 16299504
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitors of mitochondrial permeability transition pore prevent apoptosis of dopaminergic neurons in the mesencephalon].
Talanov SO; Sahach VF; Oleshko MM; Maĭs'kyĭ VO
Fiziol Zh (1994); 2006; 52(4):13-8. PubMed ID: 16958211
[TBL] [Abstract][Full Text] [Related]
16. Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness.
Hornykiewicz O
Neurodegener Dis; 2008; 5(3-4):114-7. PubMed ID: 18322366
[TBL] [Abstract][Full Text] [Related]
17. Search for the presence of glucocorticoid receptors in dopaminergic neurons of rat ventral tegmental area and substantia nigra.
Czyrak A; Chocyk A
Pol J Pharmacol; 2001; 53(6):681-4. PubMed ID: 11985346
[TBL] [Abstract][Full Text] [Related]
18. Dopamine and extrapyramidal motor function and dysfunction.
Hornykiewicz O
Res Publ Assoc Res Nerv Ment Dis; 1972; 50():390-415. PubMed ID: 4561070
[No Abstract] [Full Text] [Related]
19. Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease.
Liang CL; Wang TT; Luby-Phelps K; German DC
Exp Neurol; 2007 Feb; 203(2):370-80. PubMed ID: 17010972
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic nigrostriatal projections regulate neural precursor proliferation in the adult mouse subventricular zone.
Baker SA; Baker KA; Hagg T
Eur J Neurosci; 2004 Jul; 20(2):575-9. PubMed ID: 15233767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
